Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Water is utilized as the placebo control intervention in clinical trials sponsored by Nitric Solutions Inc., specifically for the treatment of tinea pedis (athlete's foot). In the context of these studies, it is administered as a footbath to provide a blinded comparison against the active Nitric Oxide Releasing Solution (NORS). As a placebo, it does not possess inherent antifungal activity or a specific medicinal mechanism of action for treating Trichophyton infections. Its role is to establish a baseline for evaluating the fungicidal efficacy and clinical symptom improvement of the investigational nitric oxide therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on water.